First Department of Paediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.
J Pediatr Gastroenterol Nutr. 2012 May;54(5):680-4. doi: 10.1097/MPG.0b013e31823f5fc5.
In the present study, we aimed to assess bone status and the effect of gluten-free diet (GFD) in children with celiac disease (CD), and to evaluate the predictive value of standard serum biochemical indices in the diagnosis of bone mineral density (BMD) disturbances.
Forty-five children at the time of diagnosis of CD (group A, 77.8% girls) and 36 children receiving GFD for >2 years (group B, 75% girls) were included. Sixteen children in group A were reexamined 12 months after initiation of GFD. Serum measurements of biochemical bone health indices and BMD, assessed by dual x-ray absorptiometry, were obtained.
Patients after 1 year of receiving GFD had higher BMD z scores compared with baseline (-1.45 ± 0.28 vs -0.61 ± 0.25, respectively, P = 0.004). BMD z scores were significantly lower than expected for the normal population, after 1 (P = 0.03) or at least 2 (P < 0.001) years of receiving GFD. In group B, BMD z score was positively correlated with 25-hydroxy vitamin D levels (P = 0.009). In the repeated measurements group, 25-hydroxy vitamin D differed between pre- and post-GFD (P = 0.018). No biochemical index was capable of predicting an abnormal BMD z score (receiver operating characteristic curve analysis, all of the areas under the curve <0.66).
GFD has a beneficial effect on bone health. Two years receiving diet do not ensure normalization. Biochemical markers are not indicative of BMD disturbances. Dual x-ray absorptiometry should be included in the standard management of children with CD.
本研究旨在评估儿童乳糜泻(CD)患者的骨状态和无麸质饮食(GFD)的影响,并评估标准血清生化指标在诊断骨密度(BMD)异常中的预测价值。
纳入 45 例 CD 确诊时的儿童(A 组,77.8%为女孩)和 36 例接受 GFD 治疗>2 年的儿童(B 组,75%为女孩)。A 组中有 16 例患儿在开始 GFD 治疗 12 个月后重新接受检查。获得了双能 X 线吸收法评估的血清生化骨健康指标和 BMD 的测量值。
接受 GFD 治疗 1 年后的患者 BMD z 评分较基线升高(-1.45±0.28 比-0.61±0.25,P=0.004)。接受 GFD 治疗 1 年或至少 2 年后,BMD z 评分明显低于正常人群预期值(分别为 P=0.03 和 P<0.001)。在 B 组中,BMD z 评分与 25-羟维生素 D 水平呈正相关(P=0.009)。在重复测量组中,GFD 前后 25-羟维生素 D 水平存在差异(P=0.018)。没有生化指标能够预测异常 BMD z 评分(受试者工作特征曲线分析,所有曲线下面积均<0.66)。
GFD 对骨骼健康有益。接受饮食治疗 2 年并不能确保恢复正常。生化标志物不能提示 BMD 异常。儿童 CD 患者的标准管理应包括双能 X 线吸收法。